About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Cancer Chemotherapy and Pharmacology
›
Top Articles
Cancer Chemotherapy and Pharmacology
Oncology
,
Pharmacology
3.5
(top 4%)
Impact Factor
3.7
(top 4%)
extended IF
125
(top 2%)
H-Index
3.9K
authors
8.8K
papers
199.9K
citations
6.6K
citing journals
77K
citing authors
Most Cited Articles of Cancer Chemotherapy and Pharmacology
Title
Year
Citations
Determination of subcutaneous tumor size in athymic (nude) mice
1989
1.2K
Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients
2000
550
Matrix metalloproteinases and metastasis
1999
526
Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent
1995
442
The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin
1998
434
Platinum-based drugs: past, present and future
2016
422
Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II
1982
417
Multidrug resistance: molecular mechanisms and clinical relevance
1997
416
Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis
2010
380
Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models
2007
372
Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats
2011
358
Ruthenium-based chemotherapeutics: are they ready for prime time?
2010
358
Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation
1989
336
Cancer and the tumor microenvironment: a review of an essential relationship
2009
328
The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review
1999
325
Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway
2013
314
Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity
2004
309
Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors
1995
302
A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer
2011
294
Phase I study of oxaliplatin in patients with advanced cancer
1990
281
Clinical pharmacokinetics of bevacizumab in patients with solid tumors
2008
270
A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors
2013
268
Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine
2007
263
Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine
2013
261
Advances in ovarian cancer therapy
2018
257
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.